NEKTAR THERAPEUTICS (NKTR) › Weighted Average Diluted SharesNEKTAR THERAPEUTICS (NKTR) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2016-12-31: 139.60M2017-12-31: 155.95M2018-12-31: 180.12M2019-12-31: 174.99M2020-12-31: 178.58M2021-12-31: 183.30M2022-12-31: 187.14M2023-12-31: 190.00M2024-12-31: 13.71M2025-12-31: 16.87M16.87M2016-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3116.87M+23.0%2026-03-13From 2025-01-012024-12-3113.71M-92.8%2026-03-13From 2024-01-012023-12-31190.00M+1.5%2025-03-14From 2023-01-012022-12-31187.14M+2.1%2024-03-05From 2022-01-012021-12-31183.30M+2.6%2024-03-05From 2021-01-012020-12-31178.58M+2.1%2023-02-28From 2020-01-012019-12-31174.99M-2.8%2022-03-01From 2019-01-012018-12-31180.12M+15.5%2021-02-26From 2018-01-012017-12-31155.95M+11.7%2020-02-28From 2017-01-012016-12-31139.60M—2019-03-01From 2016-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)